Open Access

Molecular epidemiological study of feline coronavirus strains in Japan using RT-PCR targeting nsp14 gene

  • Yoshikazu Tanaka1Email author,
  • Takashi Sasaki1,
  • Ryo Matsuda1,
  • Yosuke Uematsu2 and
  • Tomohiro Yamaguchi2
Contributed equally
BMC Veterinary Research201511:57

https://doi.org/10.1186/s12917-015-0372-2

Received: 21 June 2014

Accepted: 24 February 2015

Published: 11 March 2015

Abstract

Background

Feline infectious peritonitis is a fatal disease of cats caused by infection with feline coronavirus (FCoV). For detecting or genotyping of FCoV, some RT-PCR plus nested PCR techniques have been reported previously. However, referring to the whole genome sequences (WGSs) registered at NCBI, there are no detection methods that can tolerate the genetic diversity among FCoV population. In addition, the quasispecies nature of FCoV, which consists of heterogeneous variants, has been also demonstrated; thus, a universal method for heteropopulations of FCoV variants in clinical specimens is desirable.

Results

To develop an RT-PCR method for detection and genotyping of FCoV, we performed comparative genome analysis using WGSs of 32 FCoV, 7 CCoV and 5 TGEV strains obtained from NCBI. As the PCR target, we focused on the nsp14 coding region, which is highly conserved and phylogenetically informative, and developed a PCR method targeting nsp14 partial sequences. Among 103 ascites, 45 pleural effusion and 214 blood specimens from clinically ill cats, we could detect FCoV in 55 (53.4%), 14 (31.1%) and 19 (8.9%) specimens using the present method. Direct sequencing of PCR products and phylogenetic analysis allowed discrimination between type I- and II-FCoV serotypes. Our nsp14 amino acid sequence typing (nsp14 aa ST) showed that the FCoV clone with sequence type (ST) 42, which was the most predominant genotype of WGS strains, was prevalent in domestic cats in Japan.

Conclusions

Our nsp14 PCR scheme will contribute to virus detection, epidemiology and ecology of FCoV strains.

Keywords

Feline coronavirus Epidemiology Phylogenetic study

Background

Feline coronavirus (FCoV) can be classified into two biotypes, namely low virulent feline enteric coronavirus (FECV) and highly virulent feline infectious peritonitis virus (FIPV) [1]. Clinical appearance of FECV, if any, is characterized by mild enteritis. In contrast, FIPV efficiently replicates in macrophages/monocytes, and can lead to FIP, which is a highly lethal systemic granulomatous disease [2]. FIPV exists in two serotypes based on virus neutralizing antibodies, type I and type II [1,3]. Serotype I virus has a distinctive spike protein, while the spike protein of serotype II is a recombinant protein between feline and canine enteric coronaviruses [4]. Type I FECVs/FIPVs predominate throughout the world, but type II strains appear to be more adaptable to tissue culture. However, type I strains are more likely to cause clinical FIP signs [3]. FCoV is also common in healthy cats worldwide; less than 10% of FCoV seropositive cats develop FIP [5-9]. Therefore, measuring antibody levels against FCoV is rarely of diagnostic value in FIP. Thus, Histopathological examination of infected tissues is needed for the aetiological diagnosis of FIP [10,11].

RT-PCR plus nested PCR and real-time PCR techniques have allowed the detection or genotyping of FCoV [3,12-15]. However, they have not been fully reevaluated whether they can tolerate the genetic diversity of FCoV. In recent years, whole genome sequences of clinical strains of FCoV have been registered in the NCBI database by Rottier et al. at the J. Craig Venter Institute, and we have been able to readily obtain nucleotide sequences of the FCoV genome. With regard to genome information, there have been no reports on PCR-based methods that can tolerate the genetic diversity in whole genome sequenced FCoV strains. Thus, a detection method for all variants of FCoV is highly desirable.

In the present study, in order to construct a universal method for FCoV variants, we performed a genome-wide analysis of FCoV, and developed an RT-PCR method for detecting FCoV in clinical specimens. Consequently, direct sequencing of PCR products and phylogenetic analysis allowed discrimination between type I and II serotypes of FCoV. Using this method, we investigated the population genetics of FCoV strains from diseased cats in Japan.

Methods

Bioinformatics for FCoV, CCoV and TGEV

As shown in Additional file 1, thirty-two FCoV strains, seven canine coronavirus (CCoV) strains, four transmissible gastroenteritis coronavirus (TGEV) strains, a porcine respiratory coronavirus (PRCV) strain and a Mink coronavirus (MiCoV) strain were used for comparative genome analysis. All sequences were obtained from the NCBI database. Gene searches and annotation were carried out by GeneMarkS (http://opal.biology.gatech.edu/genemarks.cgi) [16], RAST annotation server (http://rast.nmpdr.org) [17] and the blast-based method. MAFFT v7.037 was used for multiple sequence alignment [18], and Aminosan v1.0.2011 was performed for amino-acid substitution model selection [19]. Phylogenetic inference using maximum likelihood (ML) and bootstrapping was performed using MEGA v5.05 [20].

In order to perform a genome-wide comparison among type I- and II-FCoV, CCoV and TGEV strains, we used the Genotyping tool at NCBI (http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi), which helps identify genotype and recombinant sequences using the blast-based method [21]. Default values were used; 300 for “window” and 100 for “increment”.

Cell culture and virus

Felis catus whole fetus-4 (fcwf-4; American Type Culture Collection, VA, USA) cells were maintained in Dulbecco’s modified Eagle’s medium (D-MEM, Sigma-Aldrich, Tokyo, Japan) supplemented with 10% fetal bovine serum (JRH, Nissui, Tokyo, Japan). We purified FCoV using linear sucrose gradient ultracentrifugation from FCoV 79–1146 strains (a gift from Tsutomu Hodatsu, Kitasato University, Japan) propagated in fcwf-4 cells.

RNA extraction and reverse transcription-PCR

Isogen-LS (Nippon Gene, Toyama, Japan) was used for RNA preparation from clinical specimens (whole blood, pleural fluid, ascites, pericardial effusion and cerebral fluid), and fcwf-4 cells infected with FCoV (79–1146 strain) according to the manufacturer’s protocol. Total RNA was reverse-transcribed using the PrimeScript RT-PCR kit (Perfect Real Time; Takara Bio, Shiga, Japan), as reported previously [22].

Construction of PCR method for detection and genotyping of FCoV strains

In order to construct a PCR method that detects variants in FCoV strains, primers were designed by multiple alignments of nucleotide sequences of the nsp14 genes in all whole genome-sequenced FCoV, closely related subspecies, CCoV and TGEV strains. The primer set nsp14-F (5′-GTGATGCTATCATGACTAG-3′) and nsp14-R (5′-CACCATTACAACCTTCTAA-3′) was used. The expected size of PCR products was 417 bp. The reaction mixture for PCR consisted of 4 μl of cDNA in a total volume of 25 μl composed of 1 U of Ex Taq (Takara-Bio), 10 pmol of each primer, 0.2 mM deoxynucleoside triphosphate mixture and 1× reaction buffer (Takara-Bio). Reaction mixtures were thermally cycled once at 95°C for 2 min; 40 times at 95°C for 30 s, 48°C for 35 s, and 72°C for 45 s; and then once at 72°C for 5 min. Using 6 μl of PCR sample, DNA fragments were analyzed by electrophoresis in 1× Tris-acetate-EDTA on a 1% agarose gel stained with ethidium bromide. In addition, these PCR products were directly sequenced using a Big Dye terminator (version 3.1) cycle sequencing kit (Applied Biosystems, Tokyo, Japan) with an ABI Prism 3100 genetic analyzer (Applied Biosystems).

Total RNA was extracted from the fcwf-4 cells infected with FCoV strain 79–1146, and was reverse-transcribed into cDNA. Viral cDNA was quantified using a real-time PCR method, as reported previously [22]. Using cDNA samples of known copy numbers, we evaluated the detection limit of our PCR method targeting nsp14.

Study population in molecular epidemiological study of FCoV strains from clinically ill cats in Japan

In the period between 2007 and 2014 in Japan, 372 specimens (103 ascites, 45 pleural effusion, 214 blood, 9 cerebral fluid and 1 pericardial effusion), which were obtained in the examination of clinically ill cats for the presence of FCoV, were used in the present study. To detect FCoV in clinical specimens, we performed RT-PCR using a random primer plus a single PCR targeted nsp14 constructed in the present study. To differentiate type I-FCoV from type II-FCoV or CCoV genotypes, direct sequencing of their PCR products and phylogenetic analysis were carried out.

In order to determine the significance of differences in detection rate between ascites, pleural effusion and blood specimens, relative risk and odds ratio were calculated using MedCalc software (http://www.medcalc.org/index.php).

nsp14 amino acid sequence typing (nsp14 aa ST) and comparison of genetic diversity in FCoV strains between different specimens

In order to devise a genotyping method for FCoV, we assigned an ST number to all distinct nsp14 partial amino acid sequences (135 aa) found in all FCoV strains, which were sequenced in the present study and previously registered in the NCBI database. We compared the population genetic structures of FCoV strains in Japan with whole genome-sequenced strains from 6 different countries.

Comparison of diversity and evenness indexes of FCoV strains by specimen

The diversity and evenness of ST distribution by specimen type were calculated using Simpson’s diversity index (1-λ) and Pielou’s evenness index (J’) [23,24]. These parameters have generally been used for comparisons of biodiversity between geographically or ecologically separated environments. Both values range from 0 (no diversity or evenness) to 1 (extreme diversity or evenness).

Results

Genome-wide comparison between FCoV strains and closely related subspecies, CCoV and TGEV

In order to compare the genome structures between type I-FCoV and type II-FCoV, and the closely related subspecies CCoV, TGEV and PRCV, we carried out a blast-based genome-wide comparison. After performing genotyping, genomic regions of 300 bp in each viral strain were color coded according to scores (0 to 300) based on nucleotide similarities against FCoV strain UU9 (Figure 1). In the genome structures of all strains with type II-FCoV genotype, events of large-scale recombination were found in a locus that stretches for about 12,000 bp from the first half of nsp12 to upstream of the nucleocapsid gene, as reported previously [25,26]. The recombination site varied slightly from one strain to another. In the phylogenetic tree based on concatenated sequences of nsp13, nsp14, nsp15, nsp16 and spike, which are protein-coding regions located within recombinant sequences, all type II-FCoV strains were clustered into a clade belonging to canine coronavirus strains (data not shown). Among the alpha-coronavirus 1 subspecies, to which FCoV, CCoV, TGEV and PRCV belonged, the coding regions from nsp14 to nsp16 were the most highly conserved (Figure 1).
Figure 1

Genome-wide comparison of FCoV, CCoV, TGEV and PRCV strains registered at NCBI database. Genomic regions of every 300 bp of strain UU9 were compared with 43 whole genome sequenced strains using BLAST Genotyping tool [21]. The blast score were visualized in a red-yellow-green gradient with green being the top score (300) and red being the bottom score (0), indicating nucleotide similarity against the corresponding region in FCoV strain UU9.

PCR method targeting nsp14 for detection of FCoV strains from clinical specimens

Based on a genome-wide comparison using the Genotyping tool at NCBI, we focused on protein-coding sequences within nsp14 to nsp16 as a candidate PCR target. The sequence region was suited to universal detection of variants because of its highly conserved sequence. Among the primer sets designed in nucleotide sequences conserved in all FCoV, CCoV, TGEV and PRCV strains, we determined the best primer set, nsp14-F and nsp14-R, which allowed amplification of 417 bp of the nsp14 partial sequences. Consequently, this PCR is universally applicable to all alpha-coronavirus 1 subspecies.

We were able to detect FCoV strains from ascites, pleural effusion, pericardial effusion and blood samples using the present method. Few nonspecific bands were found in agarose gel electrophoresis (Figure 2). Specific amplification of target sequences against all PCR products was confirmed by sequencing analysis. To evaluate the detection limit, the present method was applied to cDNA samples of known copy number using PCR. The detection limit was 4.59 × 102 copies/mL.
Figure 2

Agarose gel electrophoresis of nsp14 PCR amplification products from clinical specimens. Lane 1; pleural fluid, lane 2; ascites, lane 3; pericardial effusion, lane 4; FCoV positive whole blood by a qPCR method, lane 5; FCoV negative whole blood by a qPCR method, lane 6; fcwf-4 cells infected with FCoV strain 79–1146. M.W.M. (molecular weight marker; 100 bp ladder) is loaded on the agarose gel.

Sequence-based differentiation of type I-FCoV from type II-FCoV or CCoV

The nsp14 coding region was located on the recombination hotspot in type II-FCoV, and sequencing analysis of the region permitted discrimination between type I and II serotypes. The nucleotide identity of the nsp14 partial sequence among FCoV, CCoV, TGEV and PRCV strains ranged from 89.9 to 100%. By phylogenetic analysis based on nsp14 partial nucleotide sequences (406 bp), we were able to successfully distinguish the type I-FCoV genotype from type II-FCoV, CCoV or TGEV (Figure 3). Unfortunately, our method had no discriminating power for differentiating between type II-FCoV and CCoV genotypes.
Figure 3

Phylogenetic tree (ML method) based on nsp14 partial nucleotide sequences (406 bp). Clinical strains detected in the present study and those obtained from NCBI database were indicated by blue and black letters, respectively.

Comparison of FCoV detection rate from ascites, pleural effusion and blood in cats

Using the PCR and direct-sequencing method targeting nsp14 in the present study, we surveyed FCoV strains from clinically ill cats on which FIP was suspected but not confirmed by a complete clinico-pathological or pathological workup in veterinary hospitals in Japan. In peritoneal and pleural fluid samples, FCoV was detected in 55 of 103 (53.4%) and 14 of 45 (31.1%), respectively. All of these exhibited the type I-FCoV genotype. In a comparison of positivity rate of FCoV between peritoneal and pleural effusion samples, relative risk and odds ratio were 1.7164 and 2.5372 (95% confidence interval = 1.21-5.32, z statistic = 2.465, P = 0.0137), respectively, and we found statistically significant differences between the two.

On the other hand, positive results on nsp14 PCR from 214 blood samples, 9 cerebral fluid samples and 1 pericardial effusion sample from 224 clinically ill cats, were seen in 19 (8.9%), 0 (0%) and 1 (100%), respectively. Only one of the blood samples exhibited type II-FCoV or CCoV genotype.

Population genetics of FCoV strains in Japan by nsp14 amino acid sequence typing (nsp14 aa ST)

Using nsp 14 amino acid sequence typing (nsp14 aa ST), which was an allelic analysis based on 135 amino acid residue of nsp14, we identified fifty-three unique STs among the 89 FCoV-positive samples in this study, and 39 whole genome-sequenced FCoV and CCoV strains registered in the NCBI database (Additional file 2) [27-29]. The assigned ST numbers of nsp14 aa ST in whole genome-sequenced strains are shown in Additional file 1.

As shown in Figure 4, our nsp14 aa ST indicated that the most predominant genotype among domestic cats in Japan was ST42 (24 of 89, 27.0%), which was also found most frequently in whole genome-sequenced strains, followed by ST8 (n = 10), and ST25 (n = 7), and the top three STs accounted for 46.1% of total FCoV-positive samples. Among ascites specimens in the present study, ST42 was the most frequent genotype (n = 18), followed by ST8 (n = 5) and ST25 (n = 5). Of pleural effusion and blood samples, multiple strains of ST42 (n = 4), ST8 (n = 2) and ST8 (n = 3), ST25 (n = 2), ST42 (n = 2) were identified, respectively. We were unable to find any correlations between types of specimen and STs.
Figure 4

Phylogenetic tree (ML method) based on nsp14 partial amino acid sequences (135 aa). ST distribution and number of strains from ascites, pleural effusion, blood and pericardial effusion in population genetic structure of FCoV are indicated.

As shown in Table 1, populations of FCoV strains from blood specimens showed high values for both diversity and evenness indexes, which indicates an almost random pattern. The lowest values for both diversity and evenness indexes in ascites suggested the presence of ascites-tropic clones. In addition to FCoV detection rate, population structures of FCoV strains between ascites and pleural effusion specimens also exhibited different trends.
Table 1

Diversity and evenness indexes of FCoV strains by specimens

Kind of specimen

No. of specimens

No. of strains

No. of STs

Simpson’s index (1-λ)

Pielou’s index

Predominant ST(s) a

Ascites

103

55

26

0.881

0.661

ST42

Pleural effusion

45

14

10

0.923

0.812

ST8, ST42

Blood

214

19

15

0.971

0.895

ST8, ST25, ST42

aST(s) which accounted for not less than 10% of clones in the population.

Discussion

In previous epidemiological studies, nested PCR techniques targeting 3′-UTR and spike sequences have been widely used for viral detection and discrimination between type I and II serotypes, respectively [3,12,30-36]. However, previous methods are time-consuming, and nonspecific amplification often occurs in the course of nested PCR. Our nsp14 PCR method allowed detection of FCoV using a single PCR, and little nonspecific amplification occurred during PCR in various clinical specimens, suggesting that the primer set exhibited high specificity to only viral genome. Consequently, our method allows to ascertain accurately the presence of FCoV in any type of specimen without confirmation by sequencing of PCR products. Recently, Soma et al. reported that positivity of FCoV was 44.1% (377 of 854) in ascites from cats suspected of wet FIP in Japan using the 3′-UTR nested PCR method [36]. Although a simple comparison was not clear because of different study populations, detection sensitivity of FCoV in ascites specimens of our nsp14 single PCR was comparable or better (P = 0.0746), compared with the study using the nested PCR method. There have been some reports on the quasispecies in FCoV [31,37-41]; Battilani et al. reported that quasispecies composition is correlated with the seriousness of clinical form and lesions in the organs [37]. Therefore, detection of a population that consists of a complex of heterogeneous variants is necessary in the diagnosis of FCoV infection. Consequently, this may have resulted in improved sensitivity for FCoV detection by the present PCR targeting nsp14, which is a highly conserved region among alpha-coronavirus1 subspecies. The present method is the most reliable PCR method that can tolerate the genetic diversity of FCoV.

Using the scheme of nsp14 aa ST, we found that a clone of FCoV, ST42, is prevalent in domestic cats in Japan. It is likely that the ST42 FCoV clone is also endemic worldwide, as it accounts for most of the whole genome-sequenced strains registered at NCBI. The global distribution of ST8 and ST25 FCoV clones, which are second and third most common STs after ST42 in Japan, remains to be clarified. Further epidemiological study is thus needed.

Aggregated distribution of specific STs in FCoV strains from ascites was in contrast to that of blood specimens that formed an almost random pattern, suggesting that a tropic ascites clone is present among FCoV populations. A previous study also reported differences of quasispecies compositions of FCoV in ORF7b and N region between organs [38]. Interestingly, diversity and evenness of FCoV strains from pleural effusion were similar to those of blood but not ascites. With regard to both viral detection rate and population structures, different trends between ascites and pleural effusion specimens suggest that pathology of FCoV relevant-pleural effusion or pleural FIP have markedly different characteristics from those of FCoV relevant-ascites or peritoneal FIP. Previous studies reported that genomic alteration or variability of viral population during infection could affect the organ-specificity, severity and immunological escape [37,39,41]. Although, an onset of FCoV infection or FIP highly depends on host factors, FCoV also might exhibit the pathogenic diversity by viral strains.

The so-called internal mutation hypothesis, which postulates that viruses transition from avirulent to virulent via certain mutations leading to FIP pathogenesis, is generally believed in veterinary medicine [10]. However, there have been no reports on the identification of consensus mutations in any FCoV strains; no relationship between viral phylogeny and virulence has previously been found [42-44]. Our diversity analysis did not search for mutations in the FCoV genome responsible for FIP pathogenesis, suggesting that genetically diverse FCoV clones are present in domestic cats and that dynamically selected clones can cause FCoV-related ascites or wet FIP. Other reports also suggested that sequential emergence of variants and replacing the pre-existing population occurred in FCoV under the host immune pressure [39,41]. Thus, transition to FIP may occur through changes in viral populations in a feline host rather than internal mutations.

Recently, severe acute respiratory syndrome (SARS) in 2002/2003 and Middle East respiratory syndrome (MERS) in 2012 have emerged as human infectious disease from zoonotic coronaviruses [45,46]. To trace the original infectious source of coronavirus zoonotic transmission, we need to understand the ecology and population structures of viral strains in various animal species. Although there have been reports on detection of strains with the FCoV-genotype in host species of Carnivora other than domestic cats [35,47-49], our ecological understanding of this virus remains insufficient. The present method, which was applicable to all alpha-coronavirus1 subspecies, will also contribute to our ecological understanding of this virus.

Conclusions

In conclusion, we developed a detection and genotyping tool for all variants of FCoV, and confirmed the presence of an endemic FCoV clone, ST42, in Japan and probably worldwide. The present nsp14 PCR method will contribute to molecular epidemiology and ecological findings in alpha-coronavirus 1 subspecies, including FCoV.

Notes

Abbreviations

FCoV: 

Feline coronavirus

WGSs: 

Whole genome sequences

nsp14 aa ST: 

nsp14 amino acid sequence typing

ST: 

Sequence type

FECV: 

Feline enteric coronavirus

FIPV: 

Feline infectious peritonitis virus

CCoV: 

Canine coronavirus

TGEV: 

Transmissible gastroenteritis coronavirus

PRCV: 

Porcine respiratory coronavirus

MiCoV: 

Mink coronavirus

ML: 

Maximum likelihood

SARS: 

Severe acute respiratory syndrome

MERS: 

Middle East respiratory syndrome

M.W.M: 

Molecular weight marker

Declarations

Acknowledgements

This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science and the Strategic Research Base Development Program for Private Universities from the Ministry of Education, Culture, Sports Science and Technology of Japan (MEXT), 2008–2012.

Authors’ Affiliations

(1)
Department of Veterinary Hygiene, Veterinary School, Nippon Veterinary & Life Science University
(2)
Canine Lab., Inc.

References

  1. Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, et al. Feline infectious peritonitis. ABCD guidelines on prevention and management. J Feline Med Surg. 2009;11:594–604.View ArticlePubMedGoogle Scholar
  2. Fiscus SA, Teramoto YA. Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol. 1987;61:2607–13.PubMed CentralPubMedGoogle Scholar
  3. Kummrow M, Meli ML, Haessig M, Goenczi E, Poland A, Pedersen NC, et al. Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol. 2005;12:1209–15.PubMed CentralPubMedGoogle Scholar
  4. Shiba N, Maeda K, Kato H, Mochizuki M, Iwata H. Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet Microbiol. 2007;124:348–52.View ArticlePubMedGoogle Scholar
  5. Addie DD. Clustering of feline coronaviruses in multicat households. Vet J. 2000;159:8–9.View ArticlePubMedGoogle Scholar
  6. Addie DD, Jarrett O. A study of naturally occurring feline coronavirus infections in kittens. Vet Rec. 1992;130:133–7.View ArticlePubMedGoogle Scholar
  7. Brown MA, Troyer JL, Pecon-Slattery J, Roelke ME, O’Brien SJ. Genetics and pathogenesis of feline infectious peritonitis virus. Emerg Infect Dis. 2009;15:1445–52.View ArticlePubMed CentralPubMedGoogle Scholar
  8. Kennedy M, Citino S, McNabb AH, Moffatt AS, Gertz K, Kania S. Detection of feline coronavirus in captive Felidae in the USA. J Vet Diagn Invest. 2002;14:520–2.View ArticlePubMedGoogle Scholar
  9. Pedersen NC. A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg. 2009;11:225–58.View ArticlePubMedGoogle Scholar
  10. O’Brien SJ, Troyer JL, Brown MA, Johnson WE, Antunes A, Roelke ME, et al. Emerging viruses in the Felidae: shifting paradigms. Viruses. 2012;4:236–57.View ArticlePubMed CentralPubMedGoogle Scholar
  11. Sharif S, Arshad SS, Hair-Bejo M, Omar AR, Zeenathul NA, Alazawy A. Diagnostic methods for feline coronavirus: a review. Vet Med Int. 2010:7.Google Scholar
  12. Addie DD, Schaap IA, Nicolson L, Jarrett O. Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol. 2003;84:2735–44.View ArticlePubMedGoogle Scholar
  13. Gut M, Leutenegger CM, Huder JB, Pedersen NC, Lutz H. One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses. J Virol Methods. 1999;77:37–46.View ArticlePubMedGoogle Scholar
  14. Herrewegh AA, de Groot RJ, Cepica A, Egberink HF, Horzinek MC, Rottier PJ. Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J Clin Microbiol. 1995;33:684–9.PubMed CentralPubMedGoogle Scholar
  15. Hornyak A, Balint A, Farsang A, Balka G, Hakhverdyan M, Rasmussen TB, et al. Detection of subgenomic mRNA of feline coronavirus by real-time polymerase chain reaction based on primer-probe energy transfer (P-sg-QPCR). J Virol Methods. 2012;181:155–63.View ArticlePubMedGoogle Scholar
  16. Besemer J, Lomsadze A, Borodovsky M. GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 2001;29:2607–18.View ArticlePubMed CentralPubMedGoogle Scholar
  17. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008;9:75.View ArticlePubMed CentralPubMedGoogle Scholar
  18. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30:772–80.View ArticlePubMed CentralPubMedGoogle Scholar
  19. Tanabe AS. Kakusan4 and Aminosan: two programs for comparing nonpartitioned, proportional and separate models for combined molecular phylogenetic analyses of multilocus sequence data. Mol Ecol Resour. 2011;11:914–21.View ArticlePubMedGoogle Scholar
  20. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.View ArticlePubMed CentralPubMedGoogle Scholar
  21. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res. 2004;32:W654–659.View ArticlePubMed CentralPubMedGoogle Scholar
  22. Tanaka Y, Sato Y, Osawa S, Inoue M, Tanaka S, Sasaki T. Suppression of feline coronavirus replication in vitro by cyclosporin A. Vet Res. 2012;43:41.View ArticlePubMed CentralPubMedGoogle Scholar
  23. Simpson EH. Measurement of diversity. Nature. 1949;163:688.View ArticleGoogle Scholar
  24. Pielou EC. The measurement of diversity in different types of biological collections. J Theor Biol. 1966;11:225–8.Google Scholar
  25. Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ, de Groot RJ. Feline coronavirus type II strains 79–1683 and 79–1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol. 1998;72:4508–14.PubMed CentralPubMedGoogle Scholar
  26. Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010;2:1804–20.View ArticlePubMed CentralPubMedGoogle Scholar
  27. Tekes G, Hofmann-Lehmann R, Stallkamp I, Thiel V, Thiel HJ. Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol. 2008;82:1851–9.View ArticlePubMed CentralPubMedGoogle Scholar
  28. Zhang X, Hasoksuz M, Spiro D, Halpin R, Wang S, Stollar S, et al. Complete genomic sequences, a key residue in the spike protein and deletions in nonstructural protein 3b of US strains of the virulent and attenuated coronaviruses, transmissible gastroenteritis virus and porcine respiratory coronavirus. Virology. 2007;358:424–35.View ArticlePubMed CentralPubMedGoogle Scholar
  29. Vlasova AN, Halpin R, Wang S, Ghedin E, Spiro DJ, Saif LJ. Molecular characterization of a new species in the genus Alphacoronavirus associated with mink epizootic catarrhal gastroenteritis. J Gen Virol. 2011;92:1369–79.View ArticlePubMed CentralPubMedGoogle Scholar
  30. An DJ, Jeoung HY, Jeong W, Park JY, Lee MH, Park BK. Prevalence of Korean cats with natural feline coronavirus infections. Virol J. 2011;8:455.View ArticlePubMed CentralPubMedGoogle Scholar
  31. Benetka V, Kolodziejek J, Walk K, Rennhofer M, Mostl K. M gene analysis of atypical strains of feline and canine coronavirus circulating in an Austrian animal shelter. Vet Rec. 2006;159:170–4.View ArticlePubMedGoogle Scholar
  32. Duarte A, Fernandes M, Santos N, Tavares L. Virological Survey in free-ranging wildcats (Felis silvestris) and feral domestic cats in Portugal. Vet Microbiol. 2012;158:400–4.View ArticlePubMedGoogle Scholar
  33. Duarte A, Veiga I, Tavares L. Genetic diversity and phylogenetic analysis of Feline Coronavirus sequences from Portugal. Vet Microbiol. 2009;138:163–8.View ArticlePubMedGoogle Scholar
  34. Lin CN, Su BL, Wang CH, Hsieh MW, Chueh TJ, Chueh LL. Genetic diversity and correlation with feline infectious peritonitis of feline coronavirus type I and II: a 5-year study in Taiwan. Vet Microbiol. 2009;136:233–9.View ArticlePubMedGoogle Scholar
  35. Ntafis V, Xylouri E, Mari V, Papanastassopoulou M, Papaioannou N, Thomas A, et al. Molecular characterization of a canine coronavirus NA/09 strain detected in a dog’s organs. Arch Virol. 2012;157:171–5.View ArticlePubMedGoogle Scholar
  36. Soma T, Wada M, Taharaguchi S, Tajima T. Detection of ascitic feline coronavirus RNA from cats with clinically suspected feline infectious peritonitis. J Vet Med Sci. 2013;75:1389–92.View ArticlePubMed CentralPubMedGoogle Scholar
  37. Battilani M, Coradin T, Scagliarini A, Ciulli S, Ostanello F, Prosperi S, et al. Quasispecies composition and phylogenetic analysis of feline coronaviruses (FCoVs) in naturally infected cats. FEMS Immunol Med Microbiol. 2003;39:141–7.View ArticlePubMedGoogle Scholar
  38. Gunn-Moore DA, Gunn-Moore FJ, Gruffydd-Jones TJ, Harbour DA. Detection of FcoV quasispecies using denaturing gradient gel electrophoresis. Vet Microbiol. 1999;69:127–30.View ArticlePubMedGoogle Scholar
  39. Herrewegh AA, Mahler M, Hedrich HJ, Haagmans BL, Egberink HF, Horzinek MC, et al. Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology. 1997;234:349–63.View ArticlePubMedGoogle Scholar
  40. Kennedy MA, Moore E, Wilkes RP, Citino SB, Kania SA. Analysis of genetic mutations in the 7a7b open reading frame of coronavirus of cheetahs (Acinonyx jubatus). Am J Vet Res. 2006;67:627–32.View ArticlePubMedGoogle Scholar
  41. Kiss I, Kecskemeti S, Tanyi J, Klingeborn B, Belak S. Preliminary studies on feline coronavirus distribution in naturally and experimentally infected cats. Res Vet Sci. 2000;68:237–42.View ArticlePubMedGoogle Scholar
  42. Barker EN, Tasker S, Gruffydd-Jones TJ, Tuplin CK, Burton K, Porter E, et al. Phylogenetic analysis of feline coronavirus strains in an epizootic outbreak of feline infectious peritonitis. J Vet Intern Med. 2013;27:445–50.View ArticlePubMedGoogle Scholar
  43. Chang HW, de Groot RJ, Egberink HF, Rottier PJ. Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol. 2010;91:415–20.View ArticlePubMedGoogle Scholar
  44. Chang HW, Egberink HF, Rottier PJ. Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg Infect Dis. 2011;17:744–6.View ArticlePubMed CentralPubMedGoogle Scholar
  45. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013;87:7790–2.View ArticlePubMed CentralPubMedGoogle Scholar
  46. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–94.View ArticlePubMedGoogle Scholar
  47. East ML, Moestl K, Benetka V, Pitra C, Honer OP, Wachter B, et al. Coronavirus infection of spotted hyenas in the Serengeti ecosystem. Vet Microbiol. 2004;102:1–9.View ArticlePubMedGoogle Scholar
  48. Kennedy M, Citino S, Dolorico T, McNabb AH, Moffat AS, Kania S. Detection of feline coronavirus infection in captive cheetahs (Acinonyx jubatus) by polymerase chain reaction. J Zoo Wildl Med. 2001;32:25–30.View ArticlePubMedGoogle Scholar
  49. Vijaykrishna D, Smith GJ, Zhang JX, Peiris JS, Chen H, Guan Y. Evolutionary insights into the ecology of coronaviruses. J Virol. 2007;81:4012–20.View ArticlePubMed CentralPubMedGoogle Scholar

Copyright

© Tanaka et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement